$33M in hand, Rigontec opens an office in Cambridge and sets sights on its first immuno-oncology trial
The German startup Rigontec has nailed an additional $16.5 million in financing, doubling their Series A as the RNA upstart opens a new office …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
